%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Marika Doucet, Aadil El-Turabi, Franziska Zabel, Benjamin H.M. Hunn, Nora Bengoa-Vergniory, Milena Cioroch, Mauricio Ramm, Amy M. Smith, Ariane Cruz Gomes, Gustavo Cabral de Miranda, Richard Wade-Martins, Martin F. Bachmann
Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 11 0 R/Annots 12 0 R/Contents 13 0 R/TrimBox[0 0 612 792]>>
endobj
12 0 obj
[14 0 R 15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R 38 0 R 39 0 R 40 0 R 41 0 R]
endobj
14 0 obj
<>/Border[0 0 0]/Dest(Rpone.0181844.ref001)>>
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpone.0181844.ref002)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0181844.ref002)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0181844.ref005)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0181844.ref006)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0181844.ref009)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0181844.ref010)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0181844.ref011)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0181844.ref012)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0181844.ref013)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0181844.ref014)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0181844.ref015)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0181844.ref016)>>
endobj
27 0 obj
<>/Border[0 0 0]/Dest(Rpone.0181844.ref018)>>
endobj
28 0 obj
<>/Border[0 0 0]/Dest(Rpone.0181844.ref017)>>
endobj
29 0 obj
<>/Border[0 0 0]/Dest(Rpone.0181844.ref017)>>
endobj
30 0 obj
<>/Border[0 0 0]/Dest(Rpone.0181844.ref019)>>
endobj
31 0 obj
<>/Border[0 0 0]/Dest(Rpone.0181844.ref021)>>
endobj
32 0 obj
<>/Border[0 0 0]/Dest(Rpone.0181844.ref022)>>
endobj
33 0 obj
<>/Border[0 0 0]/Dest(Rpone.0181844.ref023)>>
endobj
34 0 obj
<>/Border[0 0 0]/Dest(Rpone.0181844.ref024)>>
endobj
35 0 obj
<>/Border[0 0 0]/Dest(Rpone.0181844.ref025)>>
endobj
36 0 obj
<>/Border[0 0 0]/Dest(Rpone.0181844.ref026)>>
endobj
37 0 obj
<>/Border[0 0 0]/Dest(Rpone.0181844.ref028)>>
endobj
38 0 obj
<>/Border[0 0 0]/Dest(Rpone.0181844.ref029)>>
endobj
39 0 obj
<>/Border[0 0 0]/Dest(Rpone.0181844.ref030)>>
endobj
40 0 obj
<>/Border[0 0 0]/Dest(Rpone.0181844.ref031)>>
endobj
41 0 obj
<>/Border[0 0 0]/A 42 0 R>>
endobj
42 0 obj
<>
endobj
13 0 obj
[43 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R 52 0 R 53 0 R 54 0 R 55 0 R 56 0 R 57 0 R 58 0 R 59 0 R 60 0 R 61 0 R 62 0 R 63 0 R 64 0 R 65 0 R 66 0 R 67 0 R 68 0 R 69 0 R]
endobj
43 0 obj
<>stream
q
0.83 0.64 0.02 0 k
383.7543 662.0031 m
388.5165 662.0031 l
h
f*
392.9386 662.0031 m
397.7008 662.0031 l
h
f*
236.6929 596.9764 m
241.3984 596.9764 l
h
f*
246.6142 596.9764 m
251.3764 596.9764 l
h
f*
292.422 558.0283 m
297.1276 558.0283 l
h
f*
302.3433 558.0283 m
307.1055 558.0283 l
h
f*
238.4504 532.0063 m
247.9748 532.0063 l
h
f*
252.4535 532.0063 m
261.978 532.0063 l
h
f*
370.6016 519.0236 m
380.126 519.0236 l
h
f*
384.6047 519.0236 m
394.0724 519.0236 l
h
f*
203.4142 480.0189 m
212.9386 480.0189 l
h
f*
217.3606 480.0189 m
226.885 480.0189 l
h
f*
369.6378 441.0142 m
379.1055 441.0142 l
h
f*
384.3213 441.0142 m
393.8457 441.0142 l
h
f*
250.6961 414.9921 m
260.2205 414.9921 l
h
f*
299.5654 350.022 m
309.0898 350.022 l
h
f*
258.0661 311.0173 m
267.5339 311.0173 l
h
f*
272.7496 311.0173 m
282.274 311.0173 l
h
f*
531.5528 297.978 m
541.0772 297.978 l
h
f*
474.0661 245.9906 m
483.5339 245.9906 l
h
f*
327.1181 233.0079 m
336.5858 233.0079 l
h
f*
338.8535 233.0079 m
348.378 233.0079 l
h
f*
458.5323 206.9858 m
468.0567 206.9858 l
h
f*
473.2157 206.9858 m
482.7402 206.9858 l
h
f*
203.4142 154.9984 m
212.9386 154.9984 l
h
f*
215.1496 154.9984 m
224.674 154.9984 l
h
f*
489.9969 103.011 m
499.5213 103.011 l
h
f*
0 g
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 706.0535 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 689.1023 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Parkinson's)Tj
4.8812 0 Td
(disease)Tj
3.0104 0 Td
(\(PD\))Tj
2.1883 0 Td
(is)Tj
0.8447 0 Td
(the)Tj
1.4627 0 Td
(second)Tj
3.0047 0 Td
(most)Tj
2.1997 0 Td
(common)Tj
3.838 0 Td
(neurodegenerative)Tj
7.6535 0 Td
(disorder)Tj
3.5717 0 Td
(after)Tj
2.0296 0 Td
(Alzhei-)Tj
-34.6845 -1.3039 Td
(mer's)Tj
2.4094 0 Td
(disease)Tj
3.016 0 Td
(\(AD\),)Tj
2.5455 0 Td
(with)Tj
2.0013 0 Td
(current)Tj
3.1804 0 Td
(treatments,)Tj
4.7225 0 Td
(including)Tj
4.0422 0 Td
(pharmacological)Tj
6.8428 0 Td
(agents)Tj
2.7496 0 Td
(and)Tj
1.7348 0 Td
(deep)Tj
2.1089 0 Td
(brain)Tj
-35.3534 -1.2982 Td
(stimulation,)Tj
5.0172 0 Td
(only)Tj
1.9786 0 Td
(offering)Tj
3.3789 0 Td
(symptomatic)Tj
5.4198 0 Td
(relief)Tj
2.2394 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2585 0 Td
(2)Tj
0 g
(].)Tj
1.2643 0 Td
(PD)Tj
1.5137 0 Td
(is)Tj
0.8504 0 Td
(characterised)Tj
5.5048 0 Td
(by)Tj
1.1849 0 Td
(a)Tj
0.6519 0 Td
(loss)Tj
1.6951 0 Td
(of)Tj
1.0148 0 Td
(neurons)Tj
3.5093 0 Td
(in)Tj
-36.4816 -1.2983 Td
(the)Tj
1.4683 0 Td
(substantia)Tj
4.2576 0 Td
(nigra)Tj
2.3074 0 Td
(pars)Tj
1.8992 0 Td
(compacta)Tj
4.0818 0 Td
(region)Tj
2.8007 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(midbrain,)Tj
4.1896 0 Td
(leading)Tj
3.1294 0 Td
(to)Tj
1.0261 0 Td
(a)Tj
0.6577 0 Td
(reduction)Tj
4.1102 0 Td
(in)Tj
1.0375 0 Td
(levels)Tj
2.3754 0 Td
(of)Tj
-35.824 -1.3039 Td
(the)Tj
1.4683 0 Td
(neurotransmitter)Tj
7.0922 0 Td
(dopamine)Tj
4.2633 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(striatum.)Tj
3.8211 0 Td
(These)Tj
2.5682 0 Td
(events)Tj
2.7269 0 Td
(result)Tj
2.4491 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(typical)Tj
2.863 0 Td
(motor)Tj
2.7212 0 Td
(symp-)Tj
-34.9849 -1.2983 Td
(toms)Tj
2.2053 0 Td
(observed)Tj
3.7927 0 Td
(in)Tj
1.0375 0 Td
(PD)Tj
1.5137 0 Td
(patients)Tj
3.3675 0 Td
(\(tremor)Tj
3.3562 0 Td
(at)Tj
0.9525 0 Td
(rest,)Tj
1.8992 0 Td
(rigidity,)Tj
3.3618 0 Td
(slowness)Tj
3.7134 0 Td
(of)Tj
1.0148 0 Td
(movement\),)Tj
5.0796 0 Td
(while)Tj
2.3698 0 Td
(cognitive)Tj
-33.664 -1.2982 Td
(impairment)Tj
4.9832 0 Td
(is)Tj
0.8504 0 Td
(usually)Tj
3.0161 0 Td
(seen)Tj
1.9785 0 Td
(when)Tj
2.4038 0 Td
(other)Tj
2.3471 0 Td
(brain)Tj
2.347 0 Td
(regions,)Tj
3.3903 0 Td
(notably)Tj
3.2144 0 Td
(cortical)Tj
3.1918 0 Td
(regions,)Tj
3.3902 0 Td
(start)Tj
1.9843 0 Td
(to)Tj
1.0204 0 Td
(be)Tj
-34.1175 -1.304 Td
(affected)Tj
3.3278 0 Td
([)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(].)Tj
-2.1316 -1.2982 Td
(Protein)Tj
3.1974 0 Td
(inclusions)Tj
4.2803 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.4684 0 Td
(brain)Tj
2.3527 0 Td
(termed)Tj
3.0841 0 Td
(Lewy)Tj
2.3187 0 Td
(bodies)Tj
2.8119 0 Td
(are)Tj
1.4514 0 Td
(the)Tj
1.4683 0 Td
(pathological)Tj
5.091 0 Td
(hallmark)Tj
3.7984 0 Td
(of)Tj
1.0148 0 Td
(PD)Tj
1.5137 0 Td
(and)Tj
-36.0791 -1.2983 Td
(other)Tj
2.347 0 Td
(related)Tj
2.9424 0 Td
(disorders,)Tj
4.1669 0 Td
(such)Tj
2.0579 0 Td
(as)Tj
1.0148 0 Td
(dementia)Tj
3.9628 0 Td
(with)Tj
1.9956 0 Td
(Lewy)Tj
2.3244 0 Td
(bodies)Tj
2.8119 0 Td
(\(DLB\),)Tj
2.9764 0 Td
(and)Tj
1.7348 0 Td
(mainly)Tj
2.9877 0 Td
(contain)Tj
3.2485 0 Td
(aggre-)Tj
-34.5711 -1.2983 Td
(gated)Tj
2.3697 0 Td
(alpha-synuclein)Tj
6.531 0 Td
([)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
(].)Tj
2.5908 0 Td
(Alpha-synuclein)Tj
6.7805 0 Td
(\(a-syn\))Tj
3.05 0 Td
(is)Tj
0.8504 0 Td
(an)Tj
1.2019 0 Td
(abundant)Tj
4.0422 0 Td
(protein)Tj
3.1521 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(brain)Tj
2.3527 0 Td
(\(rep-)Tj
-35.4271 -1.3039 Td
(resenting)Tj
3.9231 0 Td
(~0.5)Tj
1.9785 0 Td
(to)Tj
1.0262 0 Td
(1%)Tj
1.4513 0 Td
(cytosolic)Tj
3.7077 0 Td
(proteins\),)Tj
4.0819 0 Td
(is)Tj
0.8447 0 Td
(primarily)Tj
3.9741 0 Td
(found)Tj
2.6136 0 Td
(in)Tj
1.0374 0 Td
(the)Tj
1.4684 0 Td
(presynaptic)Tj
4.8415 0 Td
(terminal)Tj
3.6283 0 Td
(of)Tj
-34.5767 -1.2982 Td
(neurons)Tj
3.5035 0 Td
([)Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.7405 0 Td
(11)Tj
0 g
(])Tj
1.508 0 Td
(and)Tj
1.7348 0 Td
(as)Tj
1.0148 0 Td
(little)Tj
1.9956 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.6576 0 Td
(1.5)Tj
1.3947 0 Td
(or)Tj
1.0998 0 Td
(2-fold)Tj
2.6135 0 Td
(up-regulation)Tj
5.7033 0 Td
(of)Tj
1.0148 0 Td
(a-syn)Tj
2.3697 0 Td
(expression)Tj
4.4674 0 Td
(caused)Tj
2.914 0 Td
(by)Tj
-34.7468 -1.2983 Td
(gene)Tj
2.0806 0 Td
(multiplication)Tj
5.8847 0 Td
(can)Tj
1.627 0 Td
(cause)Tj
2.3925 0 Td
(familial)Tj
3.2201 0 Td
(PD)Tj
1.5137 0 Td
([)Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.7404 0 Td
(13)Tj
0 g
(].)Tj
-17.2628 -1.3039 Td
(The)Tj
1.7858 0 Td
(mechanisms)Tj
5.2044 0 Td
(underlying)Tj
4.6034 0 Td
(accumulation)Tj
5.6749 0 Td
(of)Tj
1.0148 0 Td
(a-syn)Tj
2.3698 0 Td
(in)Tj
1.0374 0 Td
(Lewy)Tj
2.3188 0 Td
(bodies)Tj
2.8119 0 Td
(are)Tj
1.4513 0 Td
(thought)Tj
3.3676 0 Td
(to)Tj
1.0261 0 Td
(be)Tj
1.1509 0 Td
(based)Tj
-35.0133 -1.2983 Td
(on)Tj
1.2755 0 Td
(aggregation)Tj
4.8983 0 Td
(of)Tj
1.0148 0 Td
(a-syn)Tj
2.3697 0 Td
(and/or)Tj
2.9367 0 Td
(failure)Tj
2.7779 0 Td
(to)Tj
1.0262 0 Td
(clear)Tj
2.1203 0 Td
(a-syn)Tj
2.364 0 Td
(by)Tj
1.1849 0 Td
(proteolytic)Tj
4.5354 0 Td
(and)Tj
1.7291 0 Td
(autophagy)Tj
4.3824 0 Td
(pathways)Tj
-32.6152 -1.2982 Td
([)Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.7347 0 Td
(15)Tj
0 g
(].)Tj
1.7348 0 Td
(In)Tj
1.1112 0 Td
(recent)Tj
2.7099 0 Td
(years,)Tj
2.4888 0 Td
(studies)Tj
2.9877 0 Td
(have)Tj
2.058 0 Td
(also)Tj
1.7688 0 Td
(increasingly)Tj
5.0286 0 Td
(suggested)Tj
4.0762 0 Td
(that)Tj
1.7745 0 Td
(aberrant)Tj
3.6113 0 Td
(forms)Tj
2.5682 0 Td
(of)Tj
1.0147 0 Td
(a-syn,)Tj
-34.6674 -1.304 Td
(including)Tj
4.0421 0 Td
(oligomers)Tj
4.1839 0 Td
(and)Tj
1.7348 0 Td
(fibrils,)Tj
2.7496 0 Td
(may)Tj
1.9276 0 Td
(interfere)Tj
3.6396 0 Td
(with)Tj
1.9956 0 Td
(normal)Tj
3.1464 0 Td
(cellular)Tj
3.1408 0 Td
(processes,)Tj
4.1896 0 Td
(promoting)Tj
4.5241 0 Td
(fur-)Tj
-35.2741 -1.2982 Td
(ther)Tj
1.8425 0 Td
(aggregation)Tj
4.8982 0 Td
(of)Tj
1.0148 0 Td
(protein,)Tj
3.3789 0 Td
(leading)Tj
3.1294 0 Td
(to)Tj
1.0261 0 Td
(spreading)Tj
4.1329 0 Td
(of)Tj
1.0148 0 Td
(these)Tj
2.2564 0 Td
(toxic)Tj
2.1826 0 Td
(forms)Tj
2.5682 0 Td
(of)Tj
1.0148 0 Td
(a-syn)Tj
2.3641 0 Td
(from)Tj
2.2053 0 Td
(neuron)Tj
3.1465 0 Td
(to)Tj
-36.1755 -1.2983 Td
(neuron,)Tj
3.3732 0 Td
(and)Tj
1.7291 0 Td
(ultimately)Tj
4.2349 0 Td
(to)Tj
1.0261 0 Td
(neuronal)Tj
3.8268 0 Td
(death)Tj
2.4321 0 Td
([)Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(18)Tj
0 g
(].)Tj
3.5433 0 Td
(Notably,)Tj
3.6283 0 Td
(one)Tj
1.7008 0 Td
(of)Tj
1.0148 0 Td
(these)Tj
2.2507 0 Td
(reports)Tj
3.0727 0 Td
(established)Tj
4.5978 0 Td
(a)Tj
-36.4306 -1.2983 Td
(mechanistic)Tj
5.0116 0 Td
(link)Tj
1.7801 0 Td
(between)Tj
3.5263 0 Td
(transmission)Tj
5.3631 0 Td
(of)Tj
1.0205 0 Td
(one)Tj
1.6951 0 Td
(form)Tj
2.2053 0 Td
(of)Tj
1.0148 0 Td
(pathologic)Tj
4.4164 0 Td
(a-syn)Tj
2.3697 0 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.4684 0 Td
(cardinal)Tj
3.4696 0 Td
(fea-)Tj
-35.07 -1.3039 Td
(tures)Tj
2.1996 0 Td
(of)Tj
1.0148 0 Td
(PD)Tj
1.5137 0 Td
([)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
(].)Tj
2.0806 0 Td
(In)Tj
1.1055 0 Td
(this)Tj
1.6781 0 Td
(study,)Tj
2.6136 0 Td
(the)Tj
1.4683 0 Td
(authors)Tj
3.2485 0 Td
(demonstrated)Tj
5.7599 0 Td
(that)Tj
1.7802 0 Td
(a)Tj
0.652 0 Td
(single)Tj
2.5341 0 Td
(intra-striatal)Tj
5.1987 0 Td
(administra-)Tj
-32.8476 -1.2982 Td
(tion)Tj
1.8425 0 Td
(of)Tj
1.0148 0 Td
(a-syn)Tj
2.364 0 Td
(fibrils)Tj
2.5285 0 Td
(led)Tj
1.4173 0 Td
(to)Tj
1.0262 0 Td
(the)Tj
1.4683 0 Td
(cell-to-cell)Tj
4.405 0 Td
(transmission)Tj
5.3688 0 Td
(of)Tj
1.0148 0 Td
(pathologic)Tj
4.4107 0 Td
(a-syn)Tj
2.3697 0 Td
(and)Tj
1.7292 0 Td
(PD-like)Tj
-30.9598 -1.2983 Td
(pathology)Tj
4.1782 0 Td
(in)Tj
1.0318 0 Td
(anatomically)Tj
5.3348 0 Td
(interconnected)Tj
6.2532 0 Td
(brain)Tj
2.347 0 Td
(regions)Tj
3.1635 0 Td
(of)Tj
1.0148 0 Td
(wild-type)Tj
3.9911 0 Td
(mice.)Tj
2.3811 0 Td
(In)Tj
1.1055 0 Td
(addition,)Tj
3.8211 0 Td
(Lewy)Tj
-34.6221 -1.3039 Td
(pathology)Tj
4.1782 0 Td
(accumulation)Tj
5.6749 0 Td
(in)Tj
1.0375 0 Td
(this)Tj
1.6724 0 Td
(model)Tj
2.7439 0 Td
(resulted)Tj
3.4016 0 Td
(in)Tj
1.0318 0 Td
(a)Tj
0.6576 0 Td
(progressive)Tj
4.7395 0 Td
(loss)Tj
1.6951 0 Td
(of)Tj
1.0148 0 Td
(dopamine)Tj
4.269 0 Td
(neurons)Tj
3.5036 0 Td
(in)Tj
-35.6199 -1.2983 Td
(the)Tj
1.4683 0 Td
(substantia)Tj
4.2576 0 Td
(nigra)Tj
2.3074 0 Td
(pars)Tj
1.8992 0 Td
(compacta,)Tj
4.303 0 Td
(and)Tj
1.7347 0 Td
(was)Tj
1.6952 0 Td
(accompanied)Tj
5.5445 0 Td
(by)Tj
1.1849 0 Td
(reduced)Tj
3.4469 0 Td
(dopamine)Tj
4.2632 0 Td
(levels)Tj
2.3755 0 Td
(culmi-)Tj
-34.4804 -1.2983 Td
(nating)Tj
2.7779 0 Td
(in)Tj
1.0375 0 Td
(motor)Tj
2.7212 0 Td
(deficits)Tj
3.0784 0 Td
([)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
(].)Tj
-8.4188 -1.3039 Td
(Other)Tj
2.5908 0 Td
(forms)Tj
2.5682 0 Td
(of)Tj
1.0148 0 Td
(a-syn,)Tj
2.5908 0 Td
(such)Tj
2.0636 0 Td
(as)Tj
1.0148 0 Td
(oligomers,)Tj
4.4107 0 Td
(may)Tj
1.9276 0 Td
(be)Tj
1.1508 0 Td
(critical)Tj
2.9537 0 Td
(to)Tj
1.0205 0 Td
(the)Tj
1.474 0 Td
(pathogenesis)Tj
5.3518 0 Td
(of)Tj
1.0148 0 Td
(synucleino-)Tj
-32.3431 -1.2982 Td
(pathies.)Tj
3.2654 0 Td
(Certainly,)Tj
4.1443 0 Td
(a-syn)Tj
2.3584 0 Td
(oligomers)Tj
4.1782 0 Td
(have)Tj
2.0523 0 Td
(been)Tj
2.1146 0 Td
(detected)Tj
3.5546 0 Td
(in)Tj
1.0262 0 Td
(the)Tj
1.4626 0 Td
(brain)Tj
2.3415 0 Td
(of)Tj
1.0034 0 Td
(patients)Tj
3.3619 0 Td
(affected)Tj
3.3165 0 Td
(by)Tj
1.1735 0 Td
(synu-)Tj
-35.3534 -1.2983 Td
(cleinopathies)Tj
5.4651 0 Td
([)Tj
0.83 0.64 0.02 0 k
(19)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(21)Tj
0 g
(])Tj
3.3165 0 Td
(and)Tj
1.7348 0 Td
(a)Tj
0.652 0 Td
(study)Tj
2.3867 0 Td
(demonstrated)Tj
5.76 0 Td
(that)Tj
1.7802 0 Td
(the)Tj
1.4683 0 Td
(cerebrospinal)Tj
5.6239 0 Td
(fluid)Tj
2.0749 0 Td
(\(CSF\))Tj
2.5682 0 Td
(of)Tj
1.0148 0 Td
(patients)Tj
-33.8454 -1.3039 Td
(with)Tj
1.9955 0 Td
(PD)Tj
1.5137 0 Td
(contained)Tj
4.2009 0 Td
(increased)Tj
3.9969 0 Td
(levels)Tj
2.3754 0 Td
(of)Tj
1.0148 0 Td
(a-syn)Tj
2.3697 0 Td
(oligomers)Tj
4.1896 0 Td
(when)Tj
2.4038 0 Td
(compared)Tj
4.2462 0 Td
(to)Tj
1.0205 0 Td
(controls)Tj
3.4866 0 Td
([)Tj
0.83 0.64 0.02 0 k
(22)Tj
0 g
(].)Tj
2.0749 0 Td
(The)Tj
-34.8885 -1.2983 Td
(presence)Tj
3.7133 0 Td
(of)Tj
1.0148 0 Td
(extracellular)Tj
5.1307 0 Td
(a-syn)Tj
2.3641 0 Td
(in)Tj
1.0374 0 Td
(oligomeric)Tj
4.5184 0 Td
(form)Tj
2.2054 0 Td
(raises)Tj
2.4378 0 Td
(the)Tj
1.4683 0 Td
(possibility)Tj
4.2746 0 Td
(of)Tj
1.0148 0 Td
(neutralising)Tj
4.9776 0 Td
(the)Tj
1.474 0 Td
(olig-)Tj
-35.6312 -1.2982 Td
(omers)Tj
2.6985 0 Td
(using)Tj
2.3924 0 Td
(antibodies)Tj
4.3597 0 Td
(as)Tj
1.0148 0 Td
(achieved)Tj
3.702 0 Td
(by)Tj
1.1849 0 Td
(classical)Tj
3.4129 0 Td
(vaccination)Tj
4.8245 0 Td
(against)Tj
3.0331 0 Td
(infectious)Tj
4.1272 0 Td
(diseases.)Tj
3.6056 0 Td
(Indeed,)Tj
-34.3556 -1.2983 Td
(monoclonal)Tj
5.0059 0 Td
(antibodies)Tj
4.3597 0 Td
(\(mAbs\))Tj
3.2711 0 Td
(targeting)Tj
3.7928 0 Td
(a-syn)Tj
2.3697 0 Td
(have)Tj
2.0579 0 Td
(been)Tj
2.126 0 Td
(shown)Tj
2.846 0 Td
(to)Tj
1.0261 0 Td
(reduce)Tj
2.9197 0 Td
(spread)Tj
2.8516 0 Td
(and)Tj
1.7291 0 Td
(tem-)Tj
-34.3556 -1.3039 Td
(plated)Tj
2.6645 0 Td
(aggregation)Tj
4.8982 0 Td
(of)Tj
1.0148 0 Td
(endogenous)Tj
5.0627 0 Td
(a-syn)Tj
2.3697 0 Td
(by)Tj
1.1792 0 Td
(preformed)Tj
4.4674 0 Td
(fibrils)Tj
2.5285 0 Td
(\(PFFs\))Tj
2.88 0 Td
([)Tj
0.83 0.64 0.02 0 k
(23)Tj
0 g
(])Tj
1.8482 0 Td
(and)Tj
1.7291 0 Td
(related)Tj
2.948 0 Td
(neuro-)Tj
-33.5903 -1.2983 Td
(toxic)Tj
2.1769 0 Td
(effect)Tj
2.3698 0 Td
(in)Tj
1.0318 0 Td
(vitro)Tj
2.1203 0 Td
(and)Tj
1.7291 0 Td
(in)Tj
1.0375 0 Td
(vivo)Tj
1.9049 0 Td
([)Tj
0.83 0.64 0.02 0 k
(24)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(25)Tj
0 g
(].)Tj
3.2484 0 Td
(A)Tj
0.9071 0 Td
(further)Tj
3.0274 0 Td
(attractive)Tj
3.9231 0 Td
(avenue)Tj
3.0331 0 Td
(is)Tj
0.8447 0 Td
(active)Tj
2.5228 0 Td
(immunisation)Tj
5.8847 0 Td
(that)Tj
-35.7616 -1.2983 Td
(utilises)Tj
2.965 0 Td
(a)Tj
0.6519 0 Td
(vaccine)Tj
3.1918 0 Td
(to)Tj
1.0205 0 Td
(induce)Tj
2.9367 0 Td
(therapeutic)Tj
4.7281 0 Td
(antibody)Tj
3.7587 0 Td
(response.)Tj
3.9572 0 Td
(Such)Tj
2.1713 0 Td
(an)Tj
1.1962 0 Td
(approach)Tj
3.9515 0 Td
(is)Tj
0.8447 0 Td
(in)Tj
1.0318 0 Td
(development)Tj
-32.4054 -1.3039 Td
(\(by)Tj
1.5193 0 Td
(Affiris)Tj
2.7496 0 Td
(AG\))Tj
1.9559 0 Td
(for)Tj
1.389 0 Td
(AD,)Tj
1.8651 0 Td
(PD)Tj
1.5137 0 Td
(and)Tj
1.7292 0 Td
(multiple)Tj
3.5659 0 Td
(system)Tj
2.9424 0 Td
(atrophy)Tj
3.3278 0 Td
(\(MSA\))Tj
2.9537 0 Td
([)Tj
0.83 0.64 0.02 0 k
(26)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(28)Tj
0 g
(])Tj
3.3222 0 Td
(and)Tj
1.7291 0 Td
(is)Tj
0.8447 0 Td
(being)Tj
2.4321 0 Td
(trialled)Tj
-33.8397 -1.2982 Td
(in)Tj
1.0318 0 Td
(humans.)Tj
3.668 0 Td
(Clinical)Tj
3.3165 0 Td
(trials)Tj
2.194 0 Td
(using)Tj
2.3924 0 Td
(vaccines)Tj
3.5546 0 Td
(targeting)Tj
3.7928 0 Td
(a-syn)Tj
2.3697 0 Td
(are)Tj
1.4457 0 Td
(currently)Tj
3.8891 0 Td
(in)Tj
1.0318 0 Td
(Phase)Tj
2.5285 0 Td
(1)Tj
0.6916 0 Td
(and)Tj
1.7348 0 Td
(focus)Tj
2.3244 0 Td
(on)Tj
-35.9657 -1.2983 Td
(safety)Tj
2.4774 0 Td
(and)Tj
1.7291 0 Td
(tolerability.)Tj
4.7679 0 Td
(Reports)Tj
3.3222 0 Td
(for)Tj
1.3833 0 Td
(PD)Tj
1.5137 0 Td
(and)Tj
1.7347 0 Td
(MSA)Tj
2.2677 0 Td
(thus)Tj
1.9389 0 Td
(far)Tj
1.3096 0 Td
(indicate)Tj
3.4129 0 Td
(that)Tj
1.7802 0 Td
(the)Tj
1.4683 0 Td
(candidate)Tj
4.1045 0 Td
(vaccines)Tj
-33.2104 -1.3039 Td
(targeting)Tj
3.7927 0 Td
(a-syn)Tj
2.3641 0 Td
(are)Tj
1.4513 0 Td
(able)Tj
1.8312 0 Td
(to)Tj
1.0261 0 Td
(safely)Tj
2.4264 0 Td
(induce)Tj
2.9367 0 Td
(some)Tj
2.3301 0 Td
(levels)Tj
2.3754 0 Td
(of)Tj
1.0148 0 Td
(antibodies)Tj
4.3596 0 Td
(with)Tj
2.0013 0 Td
(acceptable)Tj
4.3483 0 Td
(tolerability)Tj
-32.258 -1.2983 Td
([)Tj
0.83 0.64 0.02 0 k
(29)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(30)Tj
0 g
(].)Tj
3.2541 0 Td
(Since)Tj
2.3584 0 Td
(the)Tj
1.4684 0 Td
(studies)Tj
2.9876 0 Td
(are)Tj
1.4457 0 Td
(ongoing,)Tj
3.7531 0 Td
(no)Tj
1.2755 0 Td
(information)Tj
5.0797 0 Td
(on)Tj
1.2756 0 Td
(secondary)Tj
4.2689 0 Td
(outcomes)Tj
4.0876 0 Td
(that)Tj
1.7801 0 Td
(may)Tj
1.9275 0 Td
(relate)Tj
-34.9622 -1.2983 Td
(to)Tj
1.0261 0 Td
(efficacy)Tj
3.2201 0 Td
(\(such)Tj
2.3981 0 Td
(as)Tj
1.0148 0 Td
(beneficial)Tj
4.0479 0 Td
(effect)Tj
2.3697 0 Td
(on)Tj
1.2699 0 Td
(cognitive)Tj
3.8778 0 Td
(and)Tj
1.7291 0 Td
(motor)Tj
2.7269 0 Td
(symptoms\))Tj
4.6942 0 Td
(are)Tj
1.4513 0 Td
(available)Tj
3.668 0 Td
(at)Tj
0.9524 0 Td
(this)Tj
-34.4463 -1.3039 Td
(time.)Tj
1.1962 -1.2982 Td
(The)Tj
1.7858 0 Td
(use)Tj
1.5307 0 Td
(of)Tj
1.0148 0 Td
(virus-like)Tj
3.9855 0 Td
(particles)Tj
3.5603 0 Td
(\(VLPs\))Tj
3.0557 0 Td
(as)Tj
1.0148 0 Td
(B-cell)Tj
2.4888 0 Td
(vaccines)Tj
3.5546 0 Td
(to)Tj
1.0261 0 Td
(generate)Tj
3.6114 0 Td
(high)Tj
2.0069 0 Td
(titre)Tj
1.8765 0 Td
(antibody)Tj
-31.7081 -1.2983 Td
(responses)Tj
4.0932 0 Td
(against)Tj
3.0273 0 Td
(numerous)Tj
4.3087 0 Td
(biomolecules)Tj
5.4765 0 Td
(is)Tj
0.8504 0 Td
(increasingly)Tj
5.0286 0 Td
(well)Tj
1.8198 0 Td
(described)Tj
4.0535 0 Td
([)Tj
0.83 0.64 0.02 0 k
(31)Tj
0 g
(].)Tj
2.075 0 Td
(Such)Tj
2.177 0 Td
(vaccines)Tj
-32.91 -1.2983 Td
(are)Tj
1.4456 0 Td
(able)Tj
1.8312 0 Td
(to)Tj
1.0261 0 Td
(raise)Tj
2.075 0 Td
(antibody)Tj
3.7643 0 Td
(responses)Tj
4.0989 0 Td
(against)Tj
3.0274 0 Td
(self-antigens)Tj
5.2327 0 Td
(safely)Tj
2.4265 0 Td
(and)Tj
1.7291 0 Td
(with)Tj
2.0012 0 Td
(excellent)Tj
3.7191 0 Td
(tolerability,)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 464.7118 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Vaccine)Tj
3.7134 0 Td
(against)Tj
3.3803 0 Td
(alpha-synuc)Tj
5.2937 0 Td
(lein)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01818)Tj
4.089 0 Td
(44)Tj
0 g
2.0906 0 Td
(August)Tj
3.2882 0 Td
(10,)Tj
1.5874 0 Td
(2017)Tj
34.0302 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(25)Tj
/F10 1 Tf
-0.025 Tc
-66.402 84.0904 Td
(31003A_149)Tj
4.7835 0 Td
(925\).)Tj
2.1756 0 Td
(BHMH)Tj
2.6716 0 Td
(is)Tj
0.8363 0 Td
(supported)Tj
3.9898 0 Td
(by)Tj
1.1197 0 Td
(the)Tj
-15.5765 -1.3748 Td
(Rhodes)Tj
3.0685 0 Td
(Trust,)Tj
2.374 0 Td
(the)Tj
1.3748 0 Td
(Guarantors)Tj
4.3583 0 Td
(of)Tj
0.9496 0 Td
(Brain)Tj
2.1402 0 Td
(and)Tj
1.5874 0 Td
(a)Tj
-15.8528 -1.3749 Td
(Goodger)Tj
3.4299 0 Td
(and)Tj
1.5874 0 Td
(Schorstein)Tj
4.1882 0 Td
(Scholarsh)Tj
3.7064 0 Td
(ip)Tj
0.8858 0 Td
(\(University)Tj
4.2237 0 Td
(of)Tj
-18.0214 -1.3748 Td
(Oxford\).)Tj
3.2669 0 Td
(The)Tj
1.5945 0 Td
(funders)Tj
3.0402 0 Td
(had)Tj
1.5874 0 Td
(no)Tj
1.1693 0 Td
(role)Tj
1.6158 0 Td
(in)Tj
0.8858 0 Td
(study)Tj
2.2677 0 Td
(design,)Tj
-15.4276 -1.3748 Td
(data)Tj
1.7929 0 Td
(collection)Tj
3.7347 0 Td
(and)Tj
1.5945 0 Td
(analysis)Tj
2.9622 0 Td
(,)Tj
0.4464 0 Td
(decision)Tj
3.2883 0 Td
(to)Tj
0.9496 0 Td
(publish,)Tj
3.1465 0 Td
(or)Tj
-17.9151 -1.3748 Td
(preparation)Tj
4.4433 0 Td
(of)Tj
0.9496 0 Td
(the)Tj
1.3677 0 Td
(manuscript.)Tj
/F9 1 Tf
-6.7606 -2.126 Td
(Competing)Tj
4.3795 0 Td
(interests)Tj
3.3307 0 Td
(:)Tj
/F10 1 Tf
0.4819 0 Td
(The)Tj
1.5875 0 Td
(authors)Tj
3.0401 0 Td
(have)Tj
1.963 0 Td
(declared)Tj
-14.7827 -1.3748 Td
(that)Tj
1.6228 0 Td
(no)Tj
1.1693 0 Td
(competing)Tj
4.1599 0 Td
(interests)Tj
ET
endstream
endobj
44 0 obj
<>stream
endstream
endobj
45 0 obj
<>stream
endstream
endobj
46 0 obj
<>stream
endstream
endobj
47 0 obj
<>stream
endstream
endobj
48 0 obj
<>stream
endstream
endobj
49 0 obj
<>stream
endstream
endobj
50 0 obj
<>stream
endstream
endobj
51 0 obj
<>stream
endstream
endobj
52 0 obj
<>stream
endstream
endobj
53 0 obj
<>stream
endstream
endobj
54 0 obj
<>stream
endstream
endobj
55 0 obj
<>stream
endstream
endobj
56 0 obj
<>stream
endstream
endobj
57 0 obj
<>stream
endstream
endobj
58 0 obj
<>stream
endstream
endobj
59 0 obj
<>stream
endstream
endobj
60 0 obj
<>stream
endstream
endobj
61 0 obj
<>stream
endstream
endobj
62 0 obj
<>stream
endstream
endobj
63 0 obj
<>stream
endstream
endobj
64 0 obj
<>stream
endstream
endobj
65 0 obj
<>stream
endstream
endobj
66 0 obj
<>stream
endstream
endobj
67 0 obj
<>stream
endstream
endobj
68 0 obj
<>stream
endstream
endobj
69 0 obj
<>stream
BT
10.3394 73.7155 Td
(exist.)Tj
ET
Q
endstream
endobj
70 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 11 0 R/Annots 75 0 R/Contents 76 0 R/TrimBox[0 0 612 792]>>
endobj
73 0 obj
<>
endobj
77 0 obj
<>stream
/CIDInit/ProcSet findresource begin
12 dict begin begincmap
/CMapName/Adobe-Identity-UCS def
/CIDSystemInfo<>def
/CMapType 2 def
1 begincodespacerange
<0000>
endcodespacerange
14 beginbfchar
<0024><0041>
<0026><0043>
<0027><0044>
<0028><0045>
<0029><0046>
<002A><0047>
<002E><004B>
<002F><004C>
<0030><004D>
<0031><004E>
<0033><0050>
<0034><0051>
<0039><0056>
<003C><0059>
endbfchar
endcmap
CMapName currentdict /CMap defineresource pop end end
endstream
endobj
78 0 obj
<>/FontDescriptor 79 0 R/DW 600>>
endobj
79 0 obj
<>
endobj
80 0 obj
<>stream
`DSIG EBDTL\ iX EBLC+\ mL 4GDEF̥
r GSUBLcu| s NOS/2
0M VVDMX2M' B bdatL\ bloc+\ 4cmapX[ Bcvt a d fpgm62 _ gasp + @ glyf v head)x l 6hhea{<